HIGHLIGHTS
- who: . and colleagues from the Centre Hospitalier Universitaire de Toulouse, France University of Colorado, United States have published the research: How to use COVID-19 antiviral drugs in patients with chronic kidney disease, in the Journal: (JOURNAL) of 24/09/2022
- what: The order (safest to least safe) of antivirals based on their safety profile in COVID-19 infected CKD patients is as follows.
- future: As these recommendations are reported for HCV patients with CKD so further investigations are required for evaluating the efficacy and tolerability of sofosbuvir in patients with COVID-19 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.